Inscription Capital’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.58M | Buy |
29,836
+2,629
| +10% | +$613K | 0.67% | 25 |
|
|
2026
Q1 | $6.65M | Sell |
27,207
-664
| -2% | -$155K | 0.7% | 27 |
|
|
2025
Q4 | $5.77M | Buy |
27,871
+1,566
| +6% | +$310K | 0.59% | 28 |
|
|
2025
Q3 | $4.88M | Buy |
26,305
+3,732
| +17% | +$639K | 0.53% | 32 |
|
|
2025
Q2 | $3.45M | Sell |
22,573
-1,845
| -8% | -$284K | 0.5% | 36 |
|
|
2025
Q1 | $3.86M | Buy |
+24,418
| New | +$3.82M | 0.64% | 28 |
|
|
2024
Q3 | $3.6M | Sell |
22,210
-1,503
| -6% | -$239K | 0.53% | 36 |
|
|
2024
Q2 | $3.47M | Sell |
23,713
-705
| -3% | -$105K | 0.56% | 35 |
|
|
2024
Q1 | $3.86M | Buy |
24,418
+2,748
| +13% | +$437K | 0.64% | 28 |
|
|
2023
Q4 | $3.4M | Buy |
21,670
+936
| +5% | +$144K | 0.93% | 20 |
|
|
2023
Q3 | $3.23M | Sell |
20,734
-812
| -4% | -$134K | 1.05% | 18 |
|
|
2023
Q2 | $3.57M | Buy |
21,546
+83
| +0.4% | +$13.4K | 1.11% | 16 |
|
|
2023
Q1 | $3.33M | Sell |
21,463
-285
| -1% | -$46K | 0.88% | 20 |
|
|
2022
Q4 | $3.84M | Buy |
21,748
+75
| +0.3% | +$12.9K | 1.31% | 14 |
|
|
2022
Q3 | $3.54M | Sell |
21,673
-68,007
| -76% | -$11.5M | 1% | 17 |
|
|
2022
Q2 | $15.9M | Buy |
89,680
+68,387
| +321% | +$12.2M | 2.87% | 5 |
|
|
2022
Q1 | $3.77M | Sell |
21,293
-374
| -2% | -$63.6K | 1.08% | 17 |
|
|
2021
Q4 | $3.71M | Buy |
21,667
+2,102
| +11% | +$344K | 1.01% | 23 |
|
|
2021
Q3 | $3.16M | Sell |
19,565
-89,615
| -82% | -$15.3M | 0.99% | 20 |
|
|
2021
Q2 | $18M | Buy |
109,180
+90,617
| +488% | +$15M | 2.04% | 8 |
|
|
2021
Q1 | $3.05M | Sell |
18,563
-560
| -3% | -$90.6K | 1.04% | 15 |
|
|
2020
Q4 | $3.01M | Buy |
19,123
+1,041
| +6% | +$154K | 1.16% | 16 |
|
|
2020
Q3 | $2.69M | Sell |
18,082
-151
| -0.8% | -$22.3K | 1.19% | 17 |
|
|
2020
Q2 | $2.56M | Buy |
18,233
+1,385
| +8% | +$202K | 1.42% | 15 |
|
|
2020
Q1 | $2.21M | Buy |
16,848
+482
| +3% | +$68.4K | 1.47% | 15 |
|
|
2019
Q4 | $2.39M | Buy |
16,366
+3,361
| +26% | +$456K | 1.06% | 23 |
|
|
2019
Q3 | $1.68M | Buy |
13,005
+9,813
| +307% | +$1.29M | 0.93% | 26 |
|
|
2019
Q2 | $415K | Sell |
3,192
-1,590
| -33% | -$220K | 0.31% | 66 |
|
|
2019
Q1 | $668K | Buy |
4,782
+972
| +26% | +$130K | 0.35% | 53 |
|
|
2018
Q4 | $492K | Buy |
+3,810
| New | +$531K | 0.27% | 67 |
|
Other funds holding JNJ
Inscription Capital's JNJ Position: Q2 2026 in Review
Inscription Capital increased its Johnson & Johnson (JNJ) stake by 9.7% in Q2 2026, buying an estimated $613K and bringing the position to 29,836 shares worth $7.58M. The position accounts for 0.67% of the portfolio, ranked #25.
Inscription Capital first reported a position in JNJ in Q4 2018 and has held it in 30 quarters since. The position peaked at $18M in Q2 2021. 4,678 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Inscription Capital held 29,836 shares of Johnson & Johnson worth $7.58M as of Q2 2026.
- Inscription Capital bought 2,629 Johnson & Johnson shares in Q2 2026, an estimated $613K.
- Johnson & Johnson made up 0.67% of Inscription Capital's portfolio in Q2 2026, its #25 holding.
- Inscription Capital first reported a position in Johnson & Johnson in Q4 2018 and has held it in 30 quarters since.
- Inscription Capital's Johnson & Johnson position peaked at $18M in Q2 2021.
- 4,678 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Inscription Capital's 13F filing for Q2 2026, filed 13 Aug 2026.